433 related articles for article (PubMed ID: 18264918)
1. [Thin glomerular basement membrane disease].
Frascà GM; Balestra E; Fanciulli E; Freddi P; Mazzucchelli R; Montironi R; D'Arezzo M; Sagripanti S
G Ital Nefrol; 2008; 25(1):49-56. PubMed ID: 18264918
[TBL] [Abstract][Full Text] [Related]
2. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
[TBL] [Abstract][Full Text] [Related]
3. Thin glomerular basement membrane disease.
Frascá GM; Onetti-Muda A; Renieri A
J Nephrol; 2000; 13(1):15-9. PubMed ID: 10720210
[TBL] [Abstract][Full Text] [Related]
4. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
5. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
Voskarides K; Pierides A; Deltas C
Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
[TBL] [Abstract][Full Text] [Related]
6. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
Beirowski B; Weber M; Gross O
J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
[TBL] [Abstract][Full Text] [Related]
7. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
9. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
[TBL] [Abstract][Full Text] [Related]
10. [Collagen IV (alpha3-alpha4) nephropathy].
Torra R; Tazón B; Ars E; Ballarín J
Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
[TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant Alport's syndrome: study of a large Tunisian family.
Kharrat M; Makni S; Makni K; Kammoun K; Charfeddine K; Azaeiz H; Jarraya F; Ben Hmida M; Gubler MC; Ayadi H; Hachicha J
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):320-5. PubMed ID: 16970251
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and genetic features of the Alport 'syndromes'].
Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
14. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
[TBL] [Abstract][Full Text] [Related]
15. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
Maziers N; Dahan K; Pirson Y
Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
[TBL] [Abstract][Full Text] [Related]
16. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
[TBL] [Abstract][Full Text] [Related]
17. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
[TBL] [Abstract][Full Text] [Related]
18. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
19. Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases.
Tazón Vega B; Badenas C; Ars E; Lens X; Milà M; Darnell A; Torra R
Am J Kidney Dis; 2003 Nov; 42(5):952-9. PubMed ID: 14582039
[TBL] [Abstract][Full Text] [Related]
20. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
